ARTICLE | Clinical News
Lixivaptan regulatory update
July 30, 2012 7:00 AM UTC
FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 13 to discuss an NDA from Cornerstone for lixivaptan to treat symptomatic hypervolemic hyponatremia associated with heart fai...